Amphetamine, past and present – a pharmacological and clinical perspective
David J. Heal(IDEXX Laboratories (France)), David Nutt(Imperial College London), Jane Gosden(RenaSci (United Kingdom)), Sharon L. Smith(IDEXX Laboratories (France))
Cited by 614
Related Papers
The dopamine theory of addiction: 40 years of highs and lows
|Nature reviews. Neuroscience|2015|653
Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach
|European Addiction Research|2014|442
Experimental Approaches to Anxiety and Depression
|Behavioural Pharmacology|1993|363
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
|Journal of Psychopharmacology|2014|284
Benzodiazepines: Risks and benefits. A reconsideration
|Journal of Psychopharmacology|2013|236